Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey

Published:2019-01-17 Issue:2 Volume:30 Page:129-136
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Marmor Schelomo,Jerome-D’Emilia Bonnie,Begun James W.,Hui Jane Yuet Ching,Altman Ariella M.,Kizy Scott,Tuttle Todd M.

Funder

National Center for Chronic Disease Prevention and Health Promotion

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10552-019-1126-4/fulltext.html

Reference34 articles.

1. King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A, Oskar S et al (2015) Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol 33:3945–3952

2. Portschy PR, Marmor S, Nzara R, Virnig BA, Tuttle TM (2013) Trends in incidence and management of lobular carcinoma in situ: a population-based analysis. Ann Surg Oncol 20(10):3240–3246. https://doi.org/10.1245/s10434-013-3121-4

3. Parkin CKE, Garewal S, Waugh P, Maxwell AJ (2014) Outcomes of patients with lobular in situ neoplasia of the breast: the role of vacuum-assisted biopsy. Breast 23(5):651–655. https://doi.org/10.1016/j.breast.2014.06.016 . Epub 2014 Jul 22

4. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Cancer Netw 15(4):433–451

5. Chester R, Bokinni O, Ahmed I, Kasem A (2015) UK national survey of management of breast lobular carcinoma in situ. Ann R Coll Surg 97(8):574–577. https://doi.org/10.1308/rcsann.2015.0037

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Selection of Treatment Modality for Breast Ductal Carcinoma In Situ: Experience From a Single Institution;Cancer Control;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3